This might be the real once-in-a-generation opportunity achieve reform

Renewed US pressure on pharmaceutical pricing, including the emergence of Most Favored Nation concepts under the Donald Trump administration, should not be dismissed as irrelevant to Australian policy debates or characterised as an illegitimate intrusion into domestic decision-making. …